Outcomes of Hip Arthroplasty in Patients with Preoperative Thrombocytopenia
Clinics in Orthopedic Surgery · 2024 · 16 (5) · 711
DOI: 10.4055/cios24082 ↗At a glance
Journal article in Clinics in Orthopedic Surgery, 2024. Written by Jong Jin Go and 5 co-authors. Institution: Department of Orthopedic Surgery, Seoul National University Bundang Hospital, Seongnam, Korea. Major MEDLINE topics: Arthroplasty, Replacement, Hip, Thrombocytopenia, Length of Stay. Cited 5 times so far (Crossref); 20 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: Korea Health Industry Development Institute.
Abstract (original language)
Background
Thrombocytopenia is a condition where platelet counts are below the normal range (< 150 × 103/µL), resulting in a higher risk of bleeding and affecting the results of hip arthroplasty. We assessed the impact of preoperative platelet counts on the clinical results of patients who underwent hip arthroplasty.
Methods
Between April 2003 and March 2023, 437 patients (451 hips), who had preoperative thrombocytopenia of less than 150 × 103/µL platelets, underwent hip arthroplasty. Preoperative platelet levels were categorized into severe thrombocytopenia (< 50 × 103/µL) and non-severe thrombocytopenia (50-149 × 103/µL). Total blood loss, operation time, requirement of transfusion, amount of transfusion, duration of surgical wound oozing, length of hospital stay, mortality rate at 1 year after surgery, and any complication were compared between the 2 groups.
Results
No notable differences were observed in the surgery time or the total amount of blood loss between the groups. The requirement of transfusion and the amount of transfused blood were higher in the severe thrombocytopenia group. Prolonged oozing was found in around 18% in both groups, while periprosthetic joint infections occurred in 3 of the non-severe thrombocytopenia group. No significant difference was noted in the duration of hospital stay (25.6 ± 18.3 days vs. 19.4 ± 16.6 days, p = 0.067) and 1-year mortality (22.2% vs. 11.8%, p = 0.110).
Conclusions
Hip arthroplasties are safe for patients with low platelet counts and do not lead to prolonged hospital stays. On the other hand, patients with severe thrombocytopenia tend to need blood transfusions more frequently than those with less severe thrombocytopenia.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Orthopedic Surgery, Seoul National University Bundang Hospital, Seongnam, Korea.
- Department of Health Science and Technology, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, Korea.
- Department of Orthopedic Surgery, SMG-SNU Boramae Medical Center, Seoul, Korea.
- Department of Orthopedic Surgery, Seoul National University College of Medicine, Seoul, Korea.
ORCID profiles: Jong Jin Go, Minji Han, Tae Woo Kim, Byung Kyu Park, Jung-Wee Park, Young-Kyun Lee
Funding
- Korea Health Industry Development Institute
Cite
APA
Go, J. J., Han, M., Kim, T. W., Park, B. K., Park, J. W., & Lee, Y. K. (2024). Outcomes of Hip Arthroplasty in Patients with Preoperative Thrombocytopenia. Clinics in Orthopedic Surgery, 16(5), 711. https://doi.org/10.4055/cios24082
Vancouver
Go JJ, Han M, Kim TW, Park BK, Park JW, Lee YK. Outcomes of Hip Arthroplasty in Patients with Preoperative Thrombocytopenia. Clinics in Orthopedic Surgery. 2024;16(5):711. doi:10.4055/cios24082
BibTeX
@article{Go2024,
author = {Go, Jong Jin and Han, Minji and Kim, Tae Woo and Park, Byung Kyu and Park, Jung-Wee and Lee, Young-Kyun},
title = {Outcomes of Hip Arthroplasty in Patients with Preoperative Thrombocytopenia},
journal = {Clinics in Orthopedic Surgery},
year = {2024},
volume = {16},
number = {5},
pages = {711},
doi = {10.4055/cios24082}
}
EUVIMED